The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
Open accessAbstract
Normal somatic cells have a finite life span [1] and lose telomeric DNA, present at the ends of chromosomes, each time they divide as a function of age in vivo or in culture [2-4]. In contrast, many cancer cells and cell lines established from tumours maintain their telomere length by activation of an RNA-protein complex called telomerase, an enzyme originally discovered in Tetrahymena [5], that synthesizes telomeric repeats [6-8]. These findings have led to the formation of the 'telomere hypothesis', which proposes that critical shortening of telomeric DNA due to the end-replication problem [9] is the signal for the initiation of cellular senescence [10,11]. In yeast, the EST2 gene product, the catalytic subunit of telomerase, is essential for telomere maintenance in vivo [12-14]. The recent cloning of the cDNA encoding the catalytic subunit of human telomerase (hTERT) [15,16] makes it possible to test the telomere hypothesis. In this study, we expressed hTERT in normal human diploid fibroblasts, which lack telomerase activity, to determine whether telomerase activity could be reconstituted leading to extension of replicative life span. Our results show that retroviral-mediated expression of hTERT resulted in functional telomerase activity in normal aging human cells. Moreover, reconstitution of telomerase activity in vivo led to an increase in the length of telomeric DNA and to extension of cellular life span. These findings provide direct evidence in support of the telomere hypothesis, indicating that telomere length is one factor that can determine the replicative life span of human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Telomerase activation and the resulting telomere-length maintenance leads to the bypass of senescence and ultimately to cell immortalization23,26,27.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [27]
In the citing paper
“Thus, telomere shortening in the absence of telomerase plays a critical role in signaling entry into senescence”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Vaziri and Benchimol 1998
In the citing paper
“Ectopically expressed hTERT maintains telomere length and allows unlimited growth (Bodnar et al. 1998; Counter et al. 1998; Vaziri and Benchimol 1998”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Vaziri and Benchimol 1998
In the citing paper
“Activation of telomerase results in telomere elongation, abrogation of replicative senescence, a normal karyotype and cellular immortalization.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [4]
In the citing paper
“We now know that the endpoint of this proliferative limit, termed replicative senescence, is due largely to erosion of telomeres, protective structures that cap the end of all eukaryotic chromosomes.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [4]
In the citing paper
“A number of genetic validation experiments indicate that telomere maintenance by the enzyme telomerase is a key event in the immortalization process and the continuous proliferation of a large proportion of human cancers (Bodnar et al., 1998;Vaziri and Benchimol, 1998;Hahn et al., 1999a).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Vaziri and Benchimol, 1998
In the citing paper
“transfection of cells with the gene encoding the human telomerase reverse transcriptase component (hTERT) and subsequent expression of active telomerase have been shown to extend the life spans of normal human fibroblasts and epithelial cells (25–27).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 2×
“[6–8].”
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationMorgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,099
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096 · cited 1×
“[6–8].”
Research works printed but not linked: 1
- Olovnikov, 1971, A theory of marginotomy, Doklay Biochem, 201, 394
Cited by
Sorted by citations
Items 401–500 of 991
Alterations in the p16INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts
Noble, J. R., Zhong, Z.-H., Neumann, A. A., Melki, J. R., Clark, S. J., & Reddel, R. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207440 · Cited by 53
Cellular longevity: role of apoptosis and replicative senescence
Bree, R. T., Stenson-Cox, C., Grealy, M., Byrnes, L., Gorman, A. M., & Samali, A. (2002) · Biogerontology · doi:10.1023/a:1016299812327 · Cited by 54
Serakıncı, N., Christensen, R., Graakjær, J., Cairney, C. J., Keith, W. N., Alsner, J., Saretzki, G. C., & Kølvraa, S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.01.002 · Cited by 52
Telomeres in Mammalian Male Germline Cells
Zalenskaya, I. A., & Zalensky, A. O. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)18011-9 · Cited by 56
Telomerase: Dr Jekyll or Mr Hyde?
Prescott, J. C., & Blackburn, E. H. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80055-0 · Cited by 52
Immortalization of Primary Keratinocytes and Its Application to Skin Research
Choi, M., & Lee, C.-H. (2015) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.038 · Cited by 58
Establishment of Shrimp Cell Lines: Perception and Orientation
Puthumana, J., Jose, S., & Singh, I. S. B. (2012) · Indian Journal of Virology · doi:10.1007/s13337-012-0089-9 · Cited by 51
Rankin, A. M., Faller, D. V., & Spanjaard, R. A. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3282f5d4c2 · Cited by 52
Sealey, D., Zheng, L., Taboski, M. A. S., Cruickshank, J., Ikura, M., & Harrington, L. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1160 · Cited by 53
Catalytically active human telomerase mutants with allele-specific biological properties
Kim, M. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00217-9 · Cited by 51
Cui, W., Wylie, D., Aslam, S., Dinnyés, A., King, T., Wilmut, I., & Clark, A. J. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.013250 · Cited by 51
Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
Lallet-Daher, H., Wiel, C., Gitenay, D., Navaratnam, N., Augert, A., Calvé, B. L., Verbeke, S., Carling, D., Aubert, S., Vindrieux, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3690 · Cited by 54
Telomere length maintenance in aging and carcinogenesis.
Aragona, M., Maisano, R., Panetta, S., Giudice, A., Morelli, M., Torre, I. L., & Torre, F. L. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.5.981 · Cited by 51
Yamaguchi, H., Kojima, T., Ito, T., Kimura, Y., Imamura, M., Son, S., Koizumi, J.-I., Murata, M., Nagayama, M., Nobuoka, T., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091226 · Cited by 50
Senescence: an antiviral defense that is tumor suppressive?
Reddel, R. R. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp274 · Cited by 52
Kim, H., Farris, J., Christman, S. A., Kong, B. C., Foster, L. K., O’Grady, S. M., & Foster, D. N. (2002) · Biochemical Journal · doi:10.1042/bj20011848 · Cited by 50
Telomerase activity as a measure for monitoring radiocurability of tumor cells
Sawant, S. G., Grégoire, V., Dhar, S., Umbricht, C. B., Cvilic, S., Sukumar, S. V., & Pandita, T. K. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1047 · Cited by 50
Garbe, J. C., Wong, M. P., Wigington, D., Yaswen, P., & Stampfer, M. R. (1999) · Oncogene · doi:10.1038/sj.onc.1202523 · Cited by 50
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides
Li, G., Eller, M. S., Hanna, K., & Gilchrest, B. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.019 · Cited by 49
Disruption of an hTERT–mTOR–RAPTOR protein complex by a phytochemical perillyl alcohol and rapamycin
Sundin, T., Peffley, D. M., & Hentosh, P. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1532-3 · Cited by 49
Regulation of telomerase during human placental differentiation: a role for TGFβ1
Rama, S., Suresh, Y., & Rao, A. J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00550-0 · Cited by 49
Cell Senescence in Human Aging and Disease
Fossel, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02078.x · Cited by 49
Garton, K. J., Ferri, N., & Raines, E. W. (2002) · BioTechniques · doi:10.2144/02324rr01 · Cited by 49
Veitonmäki, N., Fuxe, J., Hultdin, M., Roos, G., Pettersson, R. F., & Cao, Y. (2003) · The FASEB Journal · doi:10.1096/fj.02-0599fje · Cited by 49
Asynchronous replication timing of telomeres at opposite arms of mammalian chromosomes
Zou, Y. S., Gryaznov, S. M., Shay, J. W., Wright, W. E., & Cornforth, M. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404106101 · Cited by 52
Criscuolo, F., Smith, S., Zahn, S., Heidinger, B. J., & Haussmann, M. F. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0440 · Cited by 49
Falchetti, M. L., Larocca, L. M., & Pallini, R. (2002) · Child s Nervous System · doi:10.1007/s00381-002-0562-7 · Cited by 48
Constructing immortalized human cell lines
Yeager, T. R., & Reddel, R. R. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00011-7 · Cited by 47
Kurose, M., Kojima, T., Koizumi, J.-I., Kamekura, R., Ninomiya, T., Murata, M., Ichimiya, S., Osanai, M., Chiba, H., Himi, T., et al. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0453-z · Cited by 47
Jun, E. S., Lee, T. H., Cho, H. H., Suh, S. Y., & Jung, J. S. (2004) · Cellular Physiology and Biochemistry · doi:10.1159/000080335 · Cited by 47
Telomerase and cancer: time to move from a promising target to a clinical reality
Keith, W. N., Evans, T. R. J., & Glasspool, R. M. (2001) · The Journal of Pathology · doi:10.1002/path.1001 · Cited by 47
Non-telomeric activities of telomerase
Majerská, J., Sýkorová, E., & Fajkus, J. (2011) · Molecular BioSystems · doi:10.1039/c0mb00268b · Cited by 47
Soohoo, C., Shi, R., Lee, T. H., Huang, P., Lu, K. P., & Zhou, X. Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180174 · Cited by 47
The programmed aging paradigm: How we get old
Libertini, G. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914100034 · Cited by 48
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems
Serene, R. L. (2005) · Frontiers in bioscience · doi:10.2741/1661 · Cited by 46
Tsang, A. R., Wyatt, H. D. M., Ting, N. S. Y., & Beattie, T. L. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00810.x · Cited by 48
Nakamura, Y., Hirose, M., Matsuo, H., Tsuyama, N., Kamisango, K., & Ide, T. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.10.1718 · Cited by 46
Davis, T., & Kipling, D. (2005) · Biogerontology · doi:10.1007/s10522-005-4901-4 · Cited by 46
The Role of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer
Park, J., & Kwak, J. (2012) · PPAR Research · doi:10.1155/2012/876418 · Cited by 46
Novel Strategies for Immortalization of Human Hepatocytes
Cascio, S. M. (2001) · Artificial Organs · doi:10.1046/j.1525-1594.2001.025007529.x · Cited by 46
Telomere Loss in Somatic Cells of Drosophila Causes Cell Cycle Arrest and Apoptosis
Ahmad, K., & Golic, K. G. (1999) · Genetics · doi:10.1093/genetics/151.3.1041 · Cited by 46
Cui, W., Aslam, S., Fletcher, J. M., Wylie, D., Clinton, M., & Clark, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205981200 · Cited by 46
Zhao, Q., Wang, X., Yu, X., Zhai, Y.-X., He, X., Wu, S., & Shi, Y. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2284 · Cited by 45
Yamada, N. A., Smith, G. A., Castro, A., Roques, C. N., Boyer, J. C., & Farber, R. A. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00282-2 · Cited by 45
Absence or low number of telomere repeats at junctions of dicentric chromosomes
Wan, T. S. K., Martens, U. M., Poon, S. S. S., Tsao, S., Ha, S., & Lansdorp, P. M. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199901)24:1 · Cited by 45
Gordon, K., Ireland, H., Roberts, M., Steeghs, K., McCaul, J. A., MacDonald, D. G., & Parkinson, E. K. (2003) · PubMed · Cited by 45
Relevance and safety of telomerase for human tissue engineering
Klinger, R. Y., Blum, J. L., Hearn, B., Lebow, B., & Niklason, L. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508184103 · Cited by 45
Senescence and immortalization of human cells
Duncan, E. L., Wadhwa, R., & Kaul, S. C. (2000) · Biogerontology · doi:10.1023/a:1010000132671 · Cited by 46
Wright, D. G., Marchal, C., Hoang, K., Ankney, J. A., Nguyen, S. T., Rushing, A. W., Polakowski, N. J., Miotto, B., & Lemasson, I. (2015) · Oncotarget · doi:10.18632/oncotarget.6424 · Cited by 49
Pallini, R., Pierconti, F., Falchetti, M. L., D’Arcangelo, D., Fernandez, E., Maira, G., D’Ambrosio, E., & Larocca, L. M. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.94.6.0961 · Cited by 44
A major role of PKC θ and NFκB in the regulation of hTERT in human T lymphocytes
Sheng, W.-Y., Chen, Y.-R., & Wang, T. V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.044 · Cited by 45
Chen, T. L., LaCerte, C., Wise, S. S., Holmes, A. L., Martino, J., Wise, J. P., Thompson, W. D., & Wise, J. P. (2011) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2011.03.011 · Cited by 43
Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop
Lai, S. R., Cunningham, A. P., Huynh, V., Andrews, L. G., & Tollefsbol, T. O. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.014 · Cited by 43
Lehner, R., Enomoto, T., McGregor, J., Shroyer, A. L., Haugen, B. R., Pugazhenthi, U., & Shroyer, K. R. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6474 · Cited by 43
Telomeric sequences, radiation sensitivity and genomic instability
Bouffler, S. D., Blasco, M. A., Cox, R., & Smith, P. J. (2001) · International Journal of Radiation Biology · doi:10.1080/09553000110069326 · Cited by 43
Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth
Vindrieux, D., Devailly, G., Augert, A., Calvé, B. L., Ferrand, M., Pigny, P., Payen, L. F., Lambeau, G. J., Perrais, M., Aubert, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1681 · Cited by 47
Quantitative analysis of hTERT mRNA expression in colorectal cancer
Niiyama, H., Mizumoto, K., Sato, N., Nagai, E., Mibu, R., Fukui, T., Kinoshita, M., & Tanaka, M. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03890.x · Cited by 42
Recent advances in the development of telomerase inhibitors for the treatment of cancer
Perry, P. J., & Jenkins, T. C. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.1981 · Cited by 42
Graf, M., Hartmann, N., Reichwald, K., & Englert, C. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.02.012 · Cited by 42
A Novel Long Non-Coding RNA in the hTERT Promoter Region Regulates hTERT Expression
Malhotra, S., Freeberg, M., Winans, S., Taylor, J., & BEEMON, K. L. (2017) · Non-Coding RNA · doi:10.3390/ncrna4010001 · Cited by 41
Telomerase as a Growth-Promoting Factor
Gorbunova, V. A., & Seluanov, A. (2003) · Cell Cycle · doi:10.4161/cc.2.6.515 · Cited by 42
TGF-β and cancer: Is Smad3 a repressor of hTERT gene?
Li, H., Xu, D., Toh, B., & Liu, J. (2006) · Cell Research · doi:10.1038/sj.cr.7310023 · Cited by 43
Telomere shortening in leukocyte subpopulations from baboons
Baerlocher, G. M., Mak, J., Röth, A., Rice, K. S., & Lansdorp, P. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0702361 · Cited by 42
Wikman, H., Risch, A., Klimek, F., Schmezer, P., Spiegelhalder, B., Dienemann, H., Kayser, K., Schulz, V., Drings, P., & Bartsch, H. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001215)88:6 · Cited by 162
MnSOD activity regulates hydroxytyrosol-induced extension of chronological lifespan
Sarsour, E. H., Kumar, M. G., Kalen, A. L., Goswami, M., Buettner, G. R., & Goswami, P. C. (2011) · AGE · doi:10.1007/s11357-011-9223-7 · Cited by 40
Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer
Shaw, V. E., Naisbitt, D. J., Costello, E., Greenhalf, W., Park, B., Neoptolemos, J. P., & Middleton, G. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.92 · Cited by 40
Hung, C. L.-K., Maiuri, T., Bowie, L. E., Gotesman, R. D., Son, S., Falcone, M., Giordano, J. V., Gillis, T., Mattis, V. B., Lau, T. C., et al. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-09-0590 · Cited by 40
Rowland, T. J., Dumbović, G., Hass, E. P., Rinn, J. L., & Cech, T. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908275116 · Cited by 41
Rowland, T. J., Bonham, A. J., & Cech, T. R. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12786 · Cited by 41
The Emerging Role of Telomerase in Cardiac Muscle Cell Growth and Survival
Oh, H., & Schneider, M. D. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2018 · Cited by 40
Telomere shortening and cell fates in mouse models of neoplasia
Artandi, S. E. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02222-5 · Cited by 40
Binding of Human Papillomavirus Type 16 E6 to E6AP Is Not Required for Activation of hTERT
Šekaric, P., Cherry, J. J., & Androphy, E. J. (2007) · Journal of Virology · doi:10.1128/jvi.01776-07 · Cited by 41
Zentgraf, U., Hinderhofer, K., & Kolb, D. (2000) · Plant Molecular Biology · doi:10.1023/a:1006324008600 · Cited by 40
Telomere length changes after umbilical cord blood transplant
Pipes, B. L., Tsang, T. C., Peng, S., Fiederlein, R. L., Graham, M. M., & Harris, D. T. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00839.x · Cited by 40
Interaction of SLP adaptors with the SH2 domain of Tec family kinases
Su, Y., Zhang, Y., Schweikert, J., Koretzky, G. A., Reth, M. G., & Wienands, J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11 · Cited by 242
Kipling, D., Wynford‐Thomas, D., Jones, C. J., Akbar, A. N., Aspinall, R., Bacchetti, S., Blasco, M. A., Broccoli, D., DePinho, R. A., Edwards, D. R., et al. (1999) · Nature Biotechnology · doi:10.1038/7827 · Cited by 40
Cellular senescence and neurodegeneration
Holloway, K., Neherin, K., Dam, K. U., & Zhang, H. (2023) · Human Genetics · doi:10.1007/s00439-023-02565-x · Cited by 40
ZEB1 stimulates breast cancer growth by up-regulating hTERT expression
Pan, Y., Shen, X. H., Yang, W., Zhang, Y., Liu, C., & Huang, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.139 · Cited by 39
Li, N. F., Broad, S., Lu, Y., Yang, J., Watson, R., Hagemann, T., Wilbanks, G. D., Jacobs, I. J., Balkwill, F. R., Dafou, D., et al. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00462.x · Cited by 39
Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide
Sato, N., Mizumoto, K., Kusumoto, M., Nishio, S., Maehara, N., Urashima, T., Ogawa, T., & Tanaka, M. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1117 · Cited by 39
Telomerase enzyme activation and human cell immortalization
Meyerson, M. M. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00278-1 · Cited by 40
Coates, P. J. (2002) · The Journal of Pathology · doi:10.1002/path.1073 · Cited by 39
Toward Identifying a Cellular Determinant of Telomerase Repression
Shay, J. W. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.4 · Cited by 39
Possible interventions to modify aging
Libertini, G., & Ferrara, N. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916120038 · Cited by 38
Rach, J., Budde, J., Möhle, N., & Aufderheide, M. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2899 · Cited by 40
Telomere Length Measurements Using Fluorescence In Situ Hybridization and Flow Cytometry
Baerlocher, G. M., & Lansdorp, P. M. (2004) · Methods in cell biology · doi:10.1016/s0091-679x(04)75031-1 · Cited by 38
Shimamoto, A., Yokote, K., & Tahara, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00010 · Cited by 38
Telomerase, Telomerase Inhibition, and Cancer
Ahmed, A., & Tollefsbol, T. O. (2003) · Rejuvenation Research · doi:10.1089/109454503323028911 · Cited by 39
Telomeres, Telomerase, and Telomerase Inhibition: Clinical Implications for Cancer
Ahmed, A., & Tollefsbol, T. O. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1601-5215.2002.51019.x · Cited by 38
Biroccio, A., Amodei, S., Antonelli, A., Benassi, B., & Zupi, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304597200 · Cited by 38
Guo, D., Zhang, L., Wang, X., Zheng, J., & Lin, S. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.956357 · Cited by 37
Gao, B., Li, K., Wei, Y.-Y., Zhang, J. C., Li, J., Zhang, L., Gao, J.-P., Li, Y., Huang, L.-G., Lin, P., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.298 · Cited by 39
He, Y., Wu, Y., He, X., Liu, F. J., He, X., & Zhang, Y. (2009) · Theriogenology · doi:10.1016/j.theriogenology.2009.01.012 · Cited by 37
Aging of perennial cells and organ parts according to the programmed aging paradigm
Libertini, G., & Ferrara, N. (2016) · AGE · doi:10.1007/s11357-016-9895-0 · Cited by 37
The Redusome Hypothesis of Aging and the Control of Biological Time during Individual Development
Olovnikov, A. M. (2003) · Biochemistry (Moscow) · doi:10.1023/a:1022185100035 · Cited by 37
Wolf, N. S., & Pendergrass, W. (1999) · The Journals of Gerontology Series A · doi:10.1093/gerona/54.11.b502 · Cited by 37
Menzel, O., Migliaccio, M., Goldstein, D. R., Dahoun, S. P., Delorenzi, M., & Rufer, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3657 · Cited by 38
Telomerase as a new target for the treatment of hormone-refractory prostate cancer
Biroccio, A., & Leonetti, C. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00764 · Cited by 37
Slatter, T. L., Gifford-Garner, J., Wiles, A. K., Tan, X., Chen, Y.-J., MacFarlane, M. R., Sullivan, M. J., Royds, J. A., & Hung, N. A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100468 · Cited by 38
Taylor, L. M., James, A. C., Schuller, C. E., Brce, J., Lock, R. B., & MacKenzie, K. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402388200 · Cited by 36
Metadata
- Authors
- Vaziri, H., & Benchimol, S.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Benchimol, Samuel
- ORCID
- Benchimol, Samuel
- Venue
- Current Biology
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 8
- Issue
- 5
- Pages
- 279-282
- ISSN
- 0960-9822 (ISSN-L)
- OpenAlex
- W2100550233
- Cited by
- 1,003
- References
- 25
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 12 · 2023: 8 · 2022: 13 · 2021: 11 · 2020: 12 · 2019: 15 · 2018: 9 · 2017: 15 · 2016: 20 · 2015: 27 · 2014: 17 · 2013: 28 · 2012: 31
- FWCI
- 48.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Current Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomerase, hTERT, telomere length, replicative lifespan, cellular senescence, telomere maintenance, retroviral gene transfer, human diploid fibroblasts, telomeric DNA, end-replication problem
- MeSH terms
- Animals, Catalysis, Cells, Cultured, DNA Replication, DNA-Binding Proteins, Fibroblasts, Humans, Protein Conformation, Proteins, Retroviridae, RNA, Tetrahymena, Telomere, Cellular Senescence, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
